SKI Market

A+| A| A-|

Indian Indices

Sensex

75,291.82 53.83
( 0.07%)

Global Indices

Nasdaq

49,543.85 -540.61
(-1.08%)

Dow Jones

7,428.26 -93.98
(-1.25%)

Hang Seng

60,874.73 -534.56
(-0.87%)

Nikkei 225

10,172.40 -200.53
(-1.93%)

Forex

USD-INR

95.71 0.07
(0.07%)

EUR-INR

111.93 -0.13
(-0.12%)

GBP-INR

129.01 -0.31
(-0.24%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Coral Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524506

INE683E01017

596.8851541

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

11.38

162.51

EPS(TTM)

Face Value()

Div & Yield %

40.01

Back

Dhansafal Finserve reports standalone net profit of Rs 0.18 crore in the December 2025 quarter

Feb 14,2026

Net profit of Dhansafal Finserve reported to Rs 0.18 crore in the quarter ended December 2025 as against net loss of Rs 0.13 crore during the previous quarter ended December 2024. Sales rose 198.31% to Rs 3.52 crore in the quarter ended December 2025 as against Rs 1.18 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	3.52	1.18	198
OPM %	33.52	-22.88	-
PBDT	0.47	-0.09	LP
PBT	0.26	-0.10	LP
NP	0.18	-0.13	LP

75,291.82 53.83 ( 0.07%)

49,543.85 -540.61 (-1.08%)

7,428.26 -93.98 (-1.25%)

60,874.73 -534.56 (-0.87%)

10,172.40 -200.53 (-1.93%)

95.71 0.07 (0.07%)

111.93 -0.13 (-0.12%)

129.01 -0.31 (-0.24%)

0.61 0.00 (-0.09%)